Skip to main content
SpringerLink
Log in

NICE recommends canagliflozin for T2DM . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. NICE. NICE consults on draft guidance recommending new drug for type 2 diabetes. Media Release : 21 Feb 2014. Available from: URL: http://www.nice.org.uk

  2. NICE. Draft guidance from NICE asks for more information on multiple sclerosis treatment - 20 February 2014. Media Release : 20 Feb 2014. Available from: URL: http://www.nice.org.uk

  3. NICE. NICE encourages further research into the effectiveness of skin cancer drug. Media Release : 25 Feb 2014. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE recommends canagliflozin for T2DM . . .. PharmacoEcon Outcomes News 697, 10 (2014). https://doi.org/10.1007/s40274-014-1083-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1083-9

Search

Navigation